CURRICULUM VITAE
A.
B.
PERSONAL INFORMATION:
Name in Full
Neena Kapoor, M.D.
Business Address
Childrens Hospital Los Angeles
4650 Sunset Boulevard, Mail Stop #62
Los Angeles, California 90027
Business Phone
323-361-2546
Home Address
3030 Paddington Road
Glendale, CA 91206
Home Phone
818-549-0243
Date of Birth
August 8, 1949
Place of Birth
Mandi, Himachal Pradesh, India
Citizenship
U.S.A.
Marital Status
Single
EDUCATION:
High School
Portmore Higher Secondary School, 1965
College or University
Dyal Singh College, India, Pre-Med, 1966
Medical School
Himachal Pradesh Medical College, MBBS, 1972
(equivalent to M.D. in U.S.A.)
ECFMG #: 179-253-0, 1973
Internship
Rhode Island Hospital
Brown University
Providence, Rhode Island
July 1973-June 1974, Pediatrics
Residencies
Rhode Island Hospital
Brown University
Providence, Rhode Island
July 1974-June 1976, Pediatrics
CURRICULUM VITAE—Neena Kapoor, MD—2010
C.
Page 2 of 29
Fellowship
Memorial Sloan Kettering Cancer Center
Cornell University
New York, New York
July 1976-June 1978, Immunology Hematology Oncology (BMT)
Licensure
California, 1994, #C-43167
Florida, 1985, #0046462
Ohio, 1987, #35-05-5204
Oklahoma, 1982, #13661
New York, 1978, #136039
Washington, D.C., 1976, #9440
Punjab Medical Council, India, 1972
N.C.I. Investigator, #14204
Board Certification
Pediatrics, American Board of Pediatrics, 1978
Pediatric Hematology/Oncology, American Board of Pediatrics, 1996
PROFESSIONAL BACKGROUND:
2003 – Present
Medical Director
Stem Cell Procurement Facility
Childrens Hospital Los Angeles
Los Angeles, California
2003 – Present
Co-Director
HLA Laboratory
Childrens Hospital Los Angeles
Los Angeles, California
1996 – Present
Director
Stem Cell Processing Laboratory
Childrens Hospital Los Angeles
Los Angeles, California
1996 - Present
Clinical Director
Clinical Bone Marrow Transplant/Research Immunology Program
Childrens Hospital Los Angeles
Los Angeles, California
Medical Director, Bone Marrow Transplant Program
Children’s Center for Cancer and Blood Diseases
Childrens Hospital Los Angeles
Los Angeles, California
1993 - 1996
Director, Pediatric Bone Marrow Transplant Program
Director, Cryopreservation and Stem Cell Laboratory
City of Hope National Medical Center
Duarte, California
CURRICULUM VITAE—Neena Kapoor, MD—2010
1987 - 1993
Director, Pediatric Bone Marrow Transplant Program
Director, Stem Cell Processing Laboratory
Ohio State University Hospital
Columbus, Ohio and Children's Hospital
Columbus, Ohio
1985 - 1987
Director, Bone Marrow Transplant Unit
All Children's Hospital
St. Petersburg, Florida
1982 - 1985
Director, Bone Marrow Transplant Service
Associate Attending Pediatrician
Oklahoma Children's Memorial Hospital
Oklahoma City, Oklahoma
Assistant Attending Pediatrician
Bone Marrow Transplantation Program
Memorial Sloan-Kettering Cancer Center
New York, New York
1978 - 1982
Page 3 of 29
1976 - 1978
Fellowship, Pediatric Immunology-Hematology-Oncology
Memorial Sloan-Kettering Cancer Center
New York, New York
1974 - 1976
Residency, Pediatrics
Rhode Island Hospital
Providence, Rhode Island
1973 - 1974
Internship
Rhode Island Hospital
Providence, Rhode Island
Hospital Appointments
1996 – present
Director , Hematopoietic Stem Cell Transplant Program
1996 - present
Medical Director, Stem Cell Processing Laboratory
2003 - present
Medical Director, Stem Cell Collection Facility
2003 – present
Co-Director, HLA Laboratory
Academic Appointments
1996 – Present
Professor of Pediatrics
University of Southern California School of Medicine
1994 - Present
Clinical Professor
University of California Irvine Appointment
1987 - 1993
Professor of Pediatrics & Medicine
Departments of Pediatrics and Internal Medicine
The Ohio State University
CURRICULUM VITAE—Neena Kapoor, MD—2010
1985 - 1987
Professor of Pediatrics
Department of Pediatrics/St. Petersburg
University of South Florida
1982 – 1985
Associate Professor of Pediatrics
Oklahoma University
1982 - 1985
Associate Member
Oklahoma Medical Research Foundation
Assistant Professor of Pediatrics
Cornell University Medical College
1978 - 1982
Page 4 of 29
1978 - 1982
Research Associate
Memorial Sloan-Kettering Cancer Center
1976 - 1978
Fellowship, Pediatric Immunology-Hematology-Oncology
Memorial Sloan-Kettering Cancer Center
1972 – 1973
Research Fellow, Otolaryngology
Boston University Hospital Medical Center
Boston, Massachusetts
Other Employment or Activities
2009 – Present
Member, Editorial Board, Journal of Cclinical Immunology
2008 – Present
Chair, Foreign Medical Graduate Affairs, ASBMT
2008 – Present
President, HP Medical College Alumni
2008 – Present
Member, Consortium of Primary Immunodeficiency Diseases
2006 – 2009
Member, Accreditation Committee, Foundation for Accreditation of
Cell Therapy (FACT)
2003 – 2008
Member, Membership Credentialing Committee, National Marrow
Donor Program (NMDP)
1999 – Present
Member, The Bone Marrow Foundation’s Medical Advisory Board
1997 – 2009
Inspector, Foundation for Accreditation of Cell Therapy (FACT)
1996 – Present
Member, Cancer Committee
Member, Operations Council for the Center for Cancer and Blood
Diseases
Director, Stem Cell Collection and Processing Laboratory
1994 - 1996
1995 - 1996
Continuing Medical Education, City of Hope National Medical Center
Quality Assessment and Improvement Committee-Member, City of
Hope National Medical Center
1995
Chairperson, Department of Health and Human Services NHLBI for
RFP for Transplant Centers for Clinical Research on Transplantation of
Umbilical Cord Stem and Progenitor Cells
CURRICULUM VITAE—Neena Kapoor, MD—2010
1993 – Present
Page 5 of 29
Medical Advisor, Asian Miracle Marrow Matches (A3M)
Honors and Awards
Distinguished Physician Award, American Association of Physicians of Indian Origin (AAPI), 1999
Humanism Award, Childrens Hospital Los Angeles, Los Angeles, CA, 2002
Formal Teaching Courses
D.
1995
Transplant Immunology Lectures to Post Graduate Students and Faculty
Members
City of Hope National Medical Center
1995
Review Course: Update in Allergy and Immunology
Sponsored by University of California Irvine
1995
Cancer and BMT Update Symposium
Sponsored by Indian Society of Oncology
1995
Lecture on Pediatric Trends and Advances in Pediatric BMT Concept
for Nursing in Nursing Education
1995
Lecture on BMT Graft Rejection and Graft vs. Host Disease
Department of Immunology
University of California Irvine
1995
Grand Rounds; Topic: Severe Aplastic Anemia
Martin Luther King Hospital
1995
Grand Rounds; Topic: Treatment of Hematological Malignancies in
1995
University of California Irvine Medical Center
1996
Transplant Immunology Lectures to Post Graduate Students and Faculty
Members
City of Hope National Medical Center
1996
Presentation for Basic Lecture Series; Topic: Peripheral Blood Stem
Cell and Cord Blood Transplantation
Charles R. Drew Medical School
1996-2009
Clinical Immunology Seminar,
University of California Irvine “Annual Course”
COMMITTEES AND SOCIETY MEMBERSHIPS
1978 – Present
1987 – Present
1989 – 2002
Member, Academy of Pediatrics
Member, American Society of Hematology
Member, International Society of Transplantation
CURRICULUM VITAE—Neena Kapoor, MD—2010
1980 – 1999
1999 – 2006
1998 – 2004
1988 – 2007
1996 – 2004
1998 – 2001
2001 – 2005
1992 - Present
1994 – 1997
1987 – Present
1987 – Present
1994 – Present
1980 – Present
1995 – Present
1999 – Present
2005 – Present
2005 – 2009
2007 – Present
2007 – Present
2007 – Present
2008 – Present
2003 – Present
2008 – Present
2009 - Present
2009 - Present
2009 – Present
2010 – Present
E.
F.
Member, International Society for Experimental Hematology
Member, Resource Management Committee, Childrens Hospital Los Angeles
Member, Nutrition Committee, Childrens Hospital Los Angeles
Member, International Society for Hematotherapy and Graft Engineering
Member, Cancer Committee, Childrens Hospital Los Angeles
Member, Operations Council, Childrens Hospital Los Angeles
Member, Accreditation Committee, NMDP
Member, American Society for Blood and Marrow Transplantation
Member-Investigator #13344, Southwest Oncology Group
Member, Children's Oncology Group
Member, California Pediatric Society
Active provider, Bureau for Children with Medical Handicaps
Member, American Association of Physicians of Indian Origin
Member, Foundation for the Accreditation of Hematopoietic Cell Therapy
Member, Blood and Tissue Committee, Childrens Hospital Los Angeles
Member, Non-Malignant Marrow Disorders Working Committee, National
Marrow Donor Program
Member, Board of Directors, American Society for Blood and Marrow
Transplantation
Member, Accreditation Committee, Foundation for the Accreditation of Cellular
Therapy
Member, Scientific Review Committee, Pediatric Blood and Marrow Transplant
Consortium
Member, GCRC Scientific Review Committee, Childrens Hospital Los Angeles
Member, Disaster Planning Committee, Childrens Hospital Los Angeles
Member, Performance Improvement Committee, Childrens Hospital Los
Angeles
Member, Scientific Review Committee, Pediatric Blood and Marrow Transplant
Consortium
Chair, Foreign Medical Graduates Committee, American Society for Blood and
Marrow Transplantation
Member, Editorial Board, Journal of Clinical Immunology
President, Shimla Medical College Alumni Association
Member, CIBMTR Nominating Committee
CONSULTANTSHIPS
1993 – Present
1991 – Present
1990 – Present
1982 – Present
Page 6 of 29
Asians for Miracle Marrow Matches (A3M)
Hinduja Medical Center; Bombay, India
Sanjay Gandhi Post-Graduate Medical Institute; Lucknow, India
Indira Gandhi Medical College; Shimla, HP, India
RESEARCH ACTIVITIES
Complete Bibliography
Appended
Major Areas of Research Interest
Histocompatible Hematopoietic Stem Cell Transplant
Graft vs. Host Disease Immunology
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 7 of 29
Viral Infections in Immunocompromised Host
Major Research in Progress
Development of T-Cell Depletion for GVHD Prophylaxis
Purging of Tumor Cells and Selection of Stem Cells
Cord Blood Cells Transplant
Selection of Hematopoietic Stem Cells for Allogeneic Bone Marrow Transplantation
Research Grants
Selection of CD34+ (Stem Cells); Supported by Baxter
Cord Blood Transplant, NHLBI
CURRENT CLINICAL ENDEAVORS
1.
Clinical Director, Bone Marrow Transplantation Program
I am the Clinical Director of the Division of Research Immunology and Bone Marrow Transplantation and
Medical Director of the Transplant Program at the Center for Cancer and Blood Diseases at Childrens
Hospital Los Angeles. In this role, I oversee the organization, function, and maintain standards of the
policies and procedures of the Bone Marrow Transplant Unit. The Transplant Program includes transplant
procedure of autologous product, and allogeneic, bone marrow, peripheral blood stem cell, cord blood cells,
both related and unrelated donors.
As attending physician on the Transplant I do clinical service, inpatient and outpatient, 8 months each year.
2.
Medical Director, Bone Marrow Procurement Under Anesthesia for Bone Marrow Transplant Program.
Director, Stem Cell Procurement Laboratory and Cryopreservation and Processing Laboratory Program.
Presently, I directly oversee processing of all peripheral blood stem cell and autologous Bone Marrow cells,
which are processed and cryopreserved. Within the program, I also have responsibility of overseeing the
activities of the cell processing laboratory for solid tumors.
Co-Director, Clinical Histocompatibility Laboratory.
5.
Co-Director, Clinical Immunology Laboratory.
PUBLICATIONS/PEER REVIEW ARTICLES
1.
Chandler B, Kapoor N, Barker B, Boyle R, Oh W: Nitroblue tetrazolium test in neonates. J. Pediatr.
92:638-640, 1978.
2.
O'Reilly RJ, Pahwa R, Kirkpatrick D, Sorell M, Kapadia A, Kapoor N, Hansen JA, Pollack M, Schutzer
SE, Good RA, Dupont B: Successful transplantation of marrow from a HLA-A, -B, -D mismatched
heterozygous sibling donor into an HLA-D-homozygous patient with aplastic anemia. Transplant. Proc.
10:957-962, 1978.
3.
Pollack M, Yang SY, O'Neill GJ, O'Reilly RJ, Grossbard E, Kapoor N, Good RA, Dupont B: Bone marrow
transplantation using typing for glyoxalase I as a tool in histocompatibility testing. Transplantation
28:156-158, 1979.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 8 of 29
4.
O'Reilly RJ, Kapoor N, Pollack M, Sorell M, Chaganti RSK, Blaese RM, Wank R, Good RA, Dupont B:
5.
Reconstitution of immunologic function in a patient with severe combined immunodeficiency following
transplantation of marrow from a HLA-A,B,C non identical but MLC-compatible paternal donor.
Transplant Proc. II:1934-1937, 1979.
6.
Gupta S, Kapoor N, Goldstein G, Good RA: Infantile thymectomy: alterations in circulating T-cell
subpopulations and in vitro effects of thymopoietin pentapeptide. Clin. Immunol. Immunopathol.
12:404-409, 1979.
7.
Broxmeyer HE, Ralph P, Margolis VB, Nakoinz I, Meyers P, Kapoor N, Moore MAS: Characteristics of
bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA). Leuk.
Res. 3:193-203, 1979.
8.
Broxmeyer HE, Pahwa R, Jacobsen N, Pelus LM, Ralph P, Meyers PA, Pahwa S, Kapoor N: Specific
inhibitory activity against granulocyte-progenitor cells produced by non-T lymphocytes from patients with
neutropenia. Exp. Hematol. 8:278-297, 1980.
9.
Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE,
Moore MAS: Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their
progeny. Blood 56:289-301, 1980.
10.
Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver DM, Dupont B, O'Reilly RJ: Dr-positive
maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host
disease. Transplantation 30:331-334, 1980.
11.
Reisner Y, Kapoor N, O'Reilly RJ, Good RA: Allogeneic bone marrow transplantation using stem cells
fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep
red blood cells and soybean agglutinin. Lancet II: 7:1320-1324, 1980.
12.
Pollack MS, Kapoor N, Sorell M, Morishima Y, Dupont B, O'Reilly RJ: Absence of demonstrable
suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of
Dr-positive maternal T cells. Transplant. Proc. 13:270-272, 1981.
13.
Platsoucas CD, Beck JD, Kapoor N, Good RA, Gupta S: Separation of human bone marrow cell
populations by density gradient electrophoresis: Differential mobilities of myeloid (CFU-C), monocytoid
and lymphoid cells. Cell. Immunol. 59:345-354, 1981.
14.
Sorell M, Kapoor N, Kirkpatrick D, Rosen JF, Chaganti RSK, Lopez C, Dupont B, Pollack MS, Terrin
BN, Harris MB, Vine D, Rose JS, Goossen C, Lane J, Good RA, O'Reilly RJ: Marrow transplantation for
juvenile osteopetrosis. Am. J. Med. 70:1280-1287, 1981.
15.
Kapoor N, Kirkpatrick D, Pollack MS, Dupont B, Reisner Y, Good RA, O'Reilly RJ: Transplantation for
acute leukemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin
and sheep red blood cells. Lancet II:327-331, 1981.
16.
Incefy GS, O'Reilly RJ, Kapoor N, Iwata T, Good RA: In vitro differentiation of human marrow T-cell
precursors by thymic factors in severe combined immunodeficiency. Transplantation 32:299-305, 1981.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 9 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
17.
Kapoor N, Kirkpatrick D, Blaese RM, Oleske J, Hilgartner MH, Chaganti RSK, Good RA, O'Reilly RJ:
Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich Syndrome
by marrow transplantation following myeloablation and immunosuppression with busulfan and
cyclophosphamide. Blood 57:692-696, 1981.
18.
Kapoor N, Kirkpatrick D, Blaese RM, Oleske J, Hilgartner MH, Chaganti RSK, Good RA, O'Reilly RJ:
Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich Syndrome
by marrow transplantation following myeloablation and immunosuppression with busulfan and
cyclophosphamide. Blood 57:692-696, 1981.
19.
Shank B, Hopfan S, Kim JH, Chu FCH, Grossbard E, Kapoor N, Kirkpatrick D, Dinsmore R, Simpson L,
Reid A, Chui C, Mohan R, Finegan D, O'Reilly RJ: Hyperfractionated total body irradiation for bone
marrow transplantation: I. Early results in leukemia patients. Int. J. Radiat. Oncol. Biol. Phys. 7:1109-1115,
1981.
20.
O’Reilly RJ, Lee FK, Grossbard E, Kapoor N, Kirkpatrick D, Dinsmore R, Stutzer C, Shah KV, Nahmias
AJ: Papovavirus excretion following marrow transplantation: Incidence and association with hepatic
dysfunction. Transplant. Proc. 13:262-266, 1981.
21.
Reisner, Y, Kapoor N, Hodes MZ, O'Reilly RJ, Good RA: Enrichment for CFU-C from murine and human
bone marrow using soybean agglutinin. Blood 59:360-363, 1982.
22.
Delmonte L, O'Reilly RJ, Kirkpatrick D, Kapoor N: In vitro model for detection of alloreactivity between
HLA-matched donor-host pairs. Transplantation 34:100-103, 1982.
23.
Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ: Identification by HLA typing of
intrauterine-derived maternal T-cells in four patients with severe combined immunodeficiency. N. Engl. J.
Med. 307:662-666, 1982.
24.
Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, Hodes MZ, Good
RA, O'Reilly RJ: Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR
incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood
61:341-348, 1983.
25.
Gupta S, Kapoor N, O'Reilly R, Good R: Spontaneous and concanavalin A induced suppressor cell activity
in patients undergoing bone marrow transplantation: Relationship with acute and chronic graft versus host
disease. J. Clin. Lab. Immunol. 10:121-125, 1983.
26.
Dinsmore RE, Reich LM, Kapoor N, Gulati S, Kirkpatrick D, Flomenberg N, O'Reilly RJ: ABH
incompatible bone marrow transplantation: Removal of erythrocytes by starch sedimentation. Br. J.
Haematol. 54:441-449, 1983.
27.
O'Reilly RJ, Kapoor N, Kirkpatrick D, Cunningham-Rundles S, Pollack MS, Dupont B, Hodes MZ, Good
RA, Reisner Y: Transplantation for severe combined immunodeficiency using histoincompatible parental
marrow fractionated by soybean agglutinin and sheep red blood cells: Experience in six consecutive cases.
Transplant. Proc. 15:1431-1435, 1983.
29.
Engelhard D, Landreth KS, Kapoor N, Kincade PW, DeBault LE, Theodore A, Good RA: Cycling of
peripheral blood and marrow lymphocytes in cyclic neutropenia. Proc. Natl. Acad. Sci. (USA)
80:5734-5738, 1983.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 10 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
30.
Jung LKL, Engelhard D, Kapoor N, Pih K, Good RA: Pyoderma eczema and folliculitis with defective
leucocyte and lymphocyte function: A new familial immunodeficiency disease responsive to a histamine-1
antagonist. Lancet 2 (8343):185-187, 1983.
31
Pollack MS, Kirkpatrick DV, Kapoor N, Callaway C, Henderson P, LeBlanc D, Cunningham-Rundles S,
Reisner Y, Dupont B, O'Reilly RJ: The use of HLA typing to monitor engraftment following transplantation
of lectin- fractionated histoincompatible marrow in patients with immunodeficiency and leukemia.
Transplant. Proc. 15:1857-1862, 1983.
32
Good RA, Kapoor N, Risner Y: Bone marrow transplantation - An expanding approach to treatment of
many diseases. Cell. Immunol. 82:36-54, 1983.
33.
Iwata T, Incefy GS, Good RA, Cunningham-Rundles S, Dardenne M, Kapoor N, Kirkpatrick D, O'Reilly
RJ: Circulating thymic hormone levels in severe combined immunodeficiency. Clin. Exp. Immunol. 53:1-9,
1983.
34.
Lazar RM, Tamaroff M, Nir Y, Freund B, O'Reilly R, Kirkpatrick D, Kapoor N: Language recovery
following isolation for severe combined immunodeficiency disease. Nature 306:54-55, 1983.
35.
Dinsmore R, Kirkpatrick D, Flomenberg N, Gulati S, Kapoor N, Shank B, Reid A, Groshen S, O'Reilly RJ:
Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood
62:381-388, 1983.
36.
O'Reilly RJ, Reich L, Gold J, Kirkpatrick D, Dinsmore R, Kapoor N, Condie R: A randomized trial of
intravenous hyperimmune globulin for the prevention of cytomegalovirus (CMV) infections following
marrow transplantation: Preliminary results. Transplant. Proc. XV:1405-1411, 1983.
37.
Shank B, Chu FCH, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Reid A, Bonfiglio P, Simpson
L, O'Reilly RJ: Hyperfractionated total body irradiation for bone marrow transplantation. Results in
seventy leukemia patients with allogeneic transplants. Int. J. Radiat. Oncol. Biol. Phys. 9:1607-1611, 1983.
38.
Kapoor N, Jung L, Bogardis C, DeBault L, Muneer R, Nitschke R, Good RA: An immunosuppressive
myeloablative preparative regimen adequate for matched sibling transplant, inadequate in histocompatible,
T-cell-depleted marrow cells is leukemia. Transplant. Proc. XVI:1419-1424, 1984.
39.
Landreth KS, Engelhard D, Beare MH, Kincade PW, Kapoor N, Good RA: Regulation of human B
lymphopoiesis: Effect of a urinary activity associated with cyclic neutropenia. J. Immunol. 134:2305-2309,
1985.
40.
Landreth KS, Engelhard D, Anasetti C, Kapoor N, Kincade PW, Good RA: Pre-B cells in
agammaglobulinemia: Evidence for disease heterogeneity among affected boys. J. Clin. Immunol. 5:84-89,
1985.
41.
Jung LKL, Fu SM, Hara T, Kapoor N, Good RA: Defective expression of T-cell associated glycoprotein
in severe combined immunodeficiency. J. Clin. Invest. 77:940-946, 1986.
42.
Engelhard D, Waner JL, Kapoor N, Good RA: Effect of intravenous immune globulin on natural killer cell
activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J. Pediatr.
108:77-81, 1986.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 11 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
43.
Kapoor N, Jung LKL, Engelhard D, Filler J, Shalit I, Landreth KS, Good RA: Lymphoma in a patient with
severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained
engraftment of histoincompatible T-cell depleted bone marrow. J. Pediatr. 108:435-438, 1986.
44.
Kapoor N, Hvizdala E, Good RA: High dose intravenous gammaglobulin as an approach to treatment of
antibody mediated pancytopenia. Br. J. Haematol 69:98-99, 1988.
45.
Copelan EC, Kapoor N, Murcek M, Theil K, Tutschka PJ: Marrow transplantation following busulfan and
cyclophosphamide as treatment for translocation (4;11) acute leukemia. Br. J. Haematol. 70:127-128,
1988.
46.
Tutschka PJ, Copelan EA, Kapoor N: Replacing total body irradiation with busulfan as conditioning of
patients with leukemia for allogeneic marrow transplantation. Transplant. Proc. XXI:2952-2954, 1989.
47.
Kapoor N, Copelan EA, Tutschka PJ: Cytomegalovirus infection in bone marrow transplant recipients: Use
of intravenous gammaglobulin as prophylactic and therapeutic agents. Transplant. Proc. XXI:3095-3096,
1989.
48.
Copelan EA, Grever MR, Kapoor N, Tutschka PJ: Marrow transplantation following busulfan and
cyclophosphamide for chronic myelogenous leukemia in accelerated or blastic phase. Br. J. Haematol.
71:487-491, 1989.
49.
Copelan EA, Kapoor N, Berliner M, Tutschka PJ: Bone marrow transplantation without total body
irradiation in patients 40 and older. Transplantation 48:65-68, 1989.
49.
Kapoor N, Copelan EA, Klein J, Tutschka PJ: Graft-versus-host disease: effects on long-term disease free
survival in marrow transplantation for hematological malignancies. Bone Marrow Transplant. 4:Suppl 4,
153-55, 1989.
50.
Incefy GS, Flomenberg N, Heller G, Kernan NA, Brochstein J, Kirkpatrick D, Kapoor N, Groshen S,
O'Reilly RJ: Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes
development of immunity in patients with lethal combined immunodeficiency transplanted with Tcell-depleted haploidentical marrow. Transplantation 50(1):55-61, 1990.
51.
Copelan EA, Kapoor N, Gibbins B, Tutschka PJ: Allogeneic marrow transplantation for non-Hodgkin's
lymphoma. Bone Marrow Transplant. 5:47-50, 1990.
52.
St. John RC, Gadek JE, Tutschka PJ, Kapoor N, Dorinsky PM: Analysis of airflow obstruction by
bronchoalveolar lavage following bone marrow transplantation: Implications for pathogenesis and
treatment. Chest 98:600-607, 1990.
53.
Tutschka PJ, Copelan EA, Kapoor N, Avalos BR, Klein J: Allogeneic bone marrow transplantation for
leukemia using chemotherapy as conditioning: 6 year results of a single institution trial. Transplant. Proc.
1:1709-1710, 1991.
54.
Copelan EA, Biggs JC, Thompson JM, Crilley P, Szer J, Klein J, Kapoor N, Avalos B, Cunningham I,
Atkinson K, Downs K, Herman G, Daly MB, Brodsky I, Bulova SI, Tutschka PJ: Treatment for acute
myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2.
Blood 78:838-843, 1991.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 12 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
55.
Ghany AM, Tutschka PJ, McGhee RB, Avalos BR, Cunningham I, Kapoor N, Copelan EA: Cyclosporineassociated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative
therapy. Transplantation 52:310-315, 1991.
56.
Copelan EA, Avalos BR, Kapoor N, Bechtel T, Tutschka PJ: Alternate applications of immunoglobulin
following bone marrow transplantation. Semin. Hematol. 29:96-99, 1992.
57.
Copelan EA, Biggs JC, Avalos BR, Szer J, Cunningham I, Klein JL, Atkinson K, Kapoor N, Klein JL,
Downs K, Tutschka PJ: Radiation-free preparation for allogeneic marrow transplantation in adults with
ALL. J. Clin. Oncol. 10:237-242, 1992.
58.
Kapoor N, Pellegrini AE, Copelan EA, Cunningham I, Avalos BR, Klein J, Tutschka PJ: PsoralenUltraviolet A (PUVA) in the treatment of chronic graft-vs-host disease. Preliminary experience in standard
treatment resistant patients. Semin. Hematol. 29:108-112, 1992.
59.
Kapoor N, Keever CA, Hsu SH, Copelan EA, Tutschka PJ: Case report: Prolonged remission of
accelerated phase Philadelphia chromosome negative chronic myeloid leukemia following autologous
recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow
transplantation. Bone Marrow Transplant. 9:143-145, 1992.
60.
Biggs JC, Szer J, Crilley P, Atkinson K, Downs K, Avalos B, Tutschka PJ, Kapoor N, Brodsky J, Topolsky
D, Copelan EA: Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation
following preparation with BuCy2. Blood 80:1352-1357, 1992.
61.
Allen CM, Kapoor N: Verruciform Xanthoma in a bone marrow transplant recipient. Oral Surg. Oral Med.
Oral Pathol. 75:591-594, 1993.
62.
Avalos BR, Klein JL, Kapoor N, Tutschka PJ, Klein JP, Copelan EA: Preparation for marrow
transplantation in Hodgkin and non-Hodgkin lymphoma using BuCy. Bone Marrow Transplant. 12:133138, 1993.
63.
Keever CA, Leong N, Klein J, Copelan EA, Avalos BR, Kapoor N, Cunningham I, Tutschka PJ: The
effects of graft-versus-host disease on the recovery of NK cell activity and LAK precursors following bone
marrow transplantation. Bone Marrow Transplant. 12:289-295, 1993.
64.
Olson TA, Kapoor N, Wing C, Tutschka P: Megakaryocyte colony stimulating activity in allogeneic bone
marrow recipients prepared with busulfan and cyclophosphamide. Br. J. Haematol. 85:365-370, 1993.
65.
Ezzone S, Jolly D, Replogle K, Kapoor N, and Tutschka J: Survey of Oral Hygiene Regimens Among Bone
Marrow Transplant Centers. Oncol. Nurs. Forum 20:1375-1380, 1993.
66.
Copelan EA, Bechtel TP, Klein JP, Klein J.L., Tutschka P, Kapoor N, Featheringham NC, Avalos B.R:
Controlled Trail of Orally Administered Immunoglobulin Following Bone Marrow Transplantation. Bone
Marrow Transplant. 13:87-91, 1994.
67.
Kapoor N. Role of Peripheral Blood Stem Cells in Intensive Chemotherapy and Transplantation.
Proceedings of Indo-US CME, December 28-29, 1996, pp. 52-53.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 13 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
68.
Kohn DB, Herschfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R,
Burroto F, Annett G, Nolta JA, Crooks G, Kapoor N, Elder M, Wara D, Bowen T, Madsen E, Snyder FF,
Bastian J, Muul L, Blaese RM, Weinberg K, and Parkman R: T Lymphocytes with a normal ADA gene
accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADAdeficient SCID neonates. Nat. Med. 4:775-780, 1998.
69.
Kapoor N, Crooks G, Kohn D, Parkman R: Hematopoietic Stem Cell Transplantation for Primary
Lymphoid Immunodeficiencies. Semin. Hematol. 35:346-353, 1998.
70.
Smith EP, Sniecinski I, Dagis AC, Parker PM, Snyder DS, Stein AS, Nademanee A, O’Donnell MR,
Molina A, Schmidt GM, Stepan DE, Kapoor N, Niland JC, Forman SF: Extracorporeal photochemotherapy
for treatment of drug-resistant graft vs. host disease. Biol. Blood. Marrow Transplant. 4:27-37, 1998.
71.
Kapoor N: Immunological recovery post hematopoietic stem cell transplantation: Role of prophylactic
antibiotics in the post transplant period. Pediatr. Transplant. 3(Suppl 1):14-18, 1998.
72.
Kapoor N, Chan R, Weinberg KI, Burotto F, Parkman R: Defective anticarbohydrate antibody responses to
naturally occurring bacteria following bone marrow transplantation. Biol. Blood Marrow Transplant. 5:4650, 1999.
73.
Nakamura CT, Ripka JF, McVeigh K, Kapoor N, Keens T: Bronchoscopic instillation of surfactant in acute
respiratory distress syndrome. Case Report, Pediatr. Pulmonol., 1999.
74.
Parkman R, Weinberg K, Crooks GM, Nolta J, Kapoor N: Gene Therapy for Adenosine Deaminase
Deficiency. Ann. Rev. Med. 51:33-47, 2000.
75.
Kapoor N, Shah AJ, Hoffman J, Crooks GM, Kohn DB, Weinberg KI, Killen R, Wilson K, Inderlied CB,
Ross LA, Parkman R: Cidofovir for Treatment of Adenoviral Infections in Pediatric Hematopoietic Stem
Cell Transplant Recipients. Blood 96(11):189, abstract #812, 2000.
76.
Kapoor N, Shah AJ, Hoffman J, Crooks GM, Kohn DB, Weinberg KI, Killen R, Wilson K, Inderlied CB,
Ross LA, Parkman R: Cidofovir for Treatment of Adenoviral Infections in Pediatric Hematopoietic Stem
Cell Transplant Recipients. Blood 96(11):189, abstract #812, 2000.
77.
Smogorzewska EM, Brooks J, Annett G, Kapoor N, Crooks GM, Kohn DB, Parkman R, Weinberg KI: T
cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined
immunodeficiency. Arch. Immunol. et Ther. Exp. 48:111-118, 2000.
78.
Nakamura CT, Ripka JF, McVeigh K, Kapoor N: Keens TG. Bronchoscopic installation of surfactant in
acute respiratory distress syndrome. Pediatr. Pulmonol. 31:317-320, 2001.
79.
Hoffman JA, Shah AJ, Ross LA, Kapoor N: Adenoviral Infections and a Prospective Trial of Cidofovir in
Pediatric Hematopoietic Stem Cell Transplantation. Biol. Blood Marrow Transplant. 7:388-394, 2001.
80.
Nakamura CT, Ripka JF, McVeigh K, Kapoor N, Keens TG: Bronchoscopic installation of surfactant in
acute respiratory distress syndrome. Pediatr. Pulmonol. 31:317-320, 2001.
81.
Kapoor N: Hematopoietic Stem Cell Transplantation: Current Status of Old Issues: J. Clin. Immunol.
21(6):377-380, 2001.
82.
Hoffman JA, Shah AJ, Ross LA, Kapoor N: Adenoviral infections and a prospective trial of cidofovir in
pediatric hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7:388-394, 2001.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 14 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
83.
Shah AJ, Kapoor N, Weinberg KI, Crooks GM, Kohn DB, Lenarsky C, Kaufman F, Epport K, Wilson K,
Parkman R: Second hematopoietic stem cell transplantation in pediatric patients: overall survival and longterm follow-up. Biol. Blood Marrow Transplant. 8:221-228, 2002.
84.
Shah AJ, Lenarsky C, Kapoor N, Crooks GM, Kohn DB, Parkman R, Epport K, Wilson K, Weinberg KI.
Busulfan and Cyclophosphamide as a Conditioning Regimen for PediatricAcute Lymphoblastic Leukemia
Patients Undergoing Bone Marrow Transplantation. J Ped Hem Oncol, 26(2): 91-97, 2002.
85.
Monforte-Munoz H, Kapoor N, Albores Saavedra J. Epstein-Barr Virus-associated Leiomyomatosis and
Posttransplant Lymphoproliferative Disorder in a Child with Severe Combined Immunodeficiency: Case
Report and Review of the Literature. Pediatric and Developmental Pathology, Vol. 6, No. 5,
September/October 2003, pp. 449-457.
86.
Donna A. Wall, Shelly L. Carter, Nancy A. Kernan, Neena Kapoor, Naynesh R. Kamani, Joel A.
Brochstein, Haydar Frangoul, Rakesh K. Goyal, John T. Horan, Daniel Pietryga, John E. Wagner, Joanne
Kurtzberg, for the COBLT Steering Committee. Busulfan/Melphalan/Antithymocyte Globulin Followed by
Unrelated Donor Cord Blood Transplantation for Treatment of Infant Luekemia and Leukemia in Young
Children: The Cord Blood Transplantation Study (COBLT) Experience. Biology of Blood and Marrow
Transplantation 11:637-646 (2005).
87.
Ami J. Shah, Neena Kapoor, Gay M. Crooks, Kenneth I. Weinberg, Hisham Abdel-Azim, Renna Killen,
Lily Kuo, Teresa Rushing, Donald B. Kohn, Robertson Parkman. The Effects of Campath 1H upon GraftVersus-Host Disease, Infection, Relapse, and Immune Reconstitution in Recipients of Pediatric Unrelated
Transplants. Biology of Blood and Marrow Transplantation 13:584-593 (2007).
88.
E.M. Smogorzweska, L. Dukes, L. Kuo, N. Kapoor. Nucleated Red Blood Cells in Normal Bone Marrow
for Transplantation. Medcyna Wieku Rozwojowego, 2007, XI, 1, 7-11.
89.
Shah AJ, Epport K, Azen C, Killen R. Wilson K, DeClerck D, Crooks G, Kapoor N, Kohn DB, Parkman
RP, Weinberg, KI. Progressive Declines in Neurocognitive Function Among Pediatric Recipients of
Hematopoietic Stem Cell Transplantation for Hematological Malignancies. J Pediatr Hematol Oncol.
30:411-418, June 2008.
90.
Joanne Kurtzberg, Vinod K. Prasad, Shelly L. Carter, John E. Wagner, Lee Ann Baxter-Lowe, Donna Wall,
Neena Kapoor, Eva C. Guinan, Stephen A. Feig, Elizabeth L. Wagner, Nancy A. Kernan and on behalf of
the COBLT Steering Committee. Results of the Cord Blood Transplantation Study (COBLT): clinical
outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic
malignancies. Blood, 2008 112: 4318-4327. Prepublished online Aug 21, 2008; doi: 10. 1182/blood-200706-098020.
91.
Bunin NJ, Davies SM, Aplee R, Camitta BM, Desantes KB, Goyal R, Kapoor N, Rosenthal J, Smith FO,
Eapen M. Unrelated donor bone marrow transplants for children with acute myeloid leukemia beyond first
remission or refractory to chemotherapy. Journal of Clinical Oncology, (2008) 26, 4326-4332.
92.
Gruber TA, Shah AJ, Hernandez M, Abdel-Azim H, Crooks GM, Kapoor N, Gupta S, McKnight S,
Schofield D, White D, and Kohn DB. Clinical and Genetic Heterogeneity in Omenn Syndrome and Severe
Combined Immune Deficiency. Pediatr Transplant. Epublish 2008 Sep 15, 2008. Pediatric Transplantation,
2009 Mar;13(2):244-50.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 15 of 29
PUBLICATIONS/PEER REVIEW ARTICLES (continued)
93.
Shah AJ, Kapoor N, Cooper RM, Crooks GM, Lenarsky C, Abdel-Azim H, Wu S, Weinberg, KI, Parkman
R, Kohn DB. Pre- and Post-Natal Treatment of Hemophagocytic Lymphohistiocytosis. Pediatr Blood
Cancer. 2009; 52:139-142.
94.
Ma, Nina S., Shah, Ami J, Geffner, Mitchell E, Kapoor, Neena. IGF-I Stimulates In Vivo Thymopoiesis
After Stem Cell Transplantation in a Child with Omenn Syndrome. J. Clin Immunol. Published Online: 24
Sep 2009.
95.
Hans D. Ochs, Alexandra H. Filipovich, Paul Veys, Morton J. Cowan, Neena Kapoor. Wiskott-Aldrich
Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and Treatment. Biology of Blood and
Marrow Transplantation. 15:84-90, 2009
NON-PEER REVIEW ARTICLES
1.
O'Reilly RJ, Pahwa R, Sorell M, Kapoor N, Kapadia A, Kirkpatrick D, Pollack M, Dupont B, Incefy G,
Iwata T, Good RA: Transplantation of fetal liver and thymus in patients with severe combined
immunodeficiencies. Proceedings of Serono Symposia, Stresa, Italy, 27:241-253, 1978.
2.
Gupta S, Kapadia A, Kapoor N, Good RA: Immunoregulatory T-cells in patients with primary
immunodeficiency diseases. Indian J. Med. Res. 69:645-650, 1979.
3.
Malaspina HC, Ciraieri D, Rabellino E, Yen A, Kapoor N, Kempin S, Moore MAS: Effects of peripheral
blood marrow cells from normal donors and patients with myeloproliferative disorders on bone marrow
fibroblast growth: Pathological considerations. Int. Soc. of Hematol, Canada, 1980.
4.
O’Reilly RJ, Kapoor N, Pollack MS, Chaganti RS, Dupont B, Kirkpatrick D, Pahwa S, Reisner Y:
Immunologic function in patients transplanted for severe combined immunodeficiency selectively engrafted
with donor T-lymphocytes. International Workshop: The influence of the thymus on the generation of the
T-cell repertoire. Rudesheim, West Germany, September16, 1981. Behring Institute Mitteilunger 70:1821877, 1982.
5.
O'Reilly RJ, Pollack MS, Kapoor N, Kirkpatrick D, Dupont B: Fetal liver transplantation in man and
animals. Recent Advances in Bone Marrow Transplantation. pp. 799-830, 1983.
6.
Stevenson RE, Sorell M, Kapoor N, Pollack M: Chimerism in an infant with severe combined
immunodeficiency. Proc. Greenwood Genet. Ctr. 3:30-33, 1984.
7.
Kapoor N: Treatment of autoimmune neutropenia with intravenous IgG. Clin. Immunol. Today
2(Nov):4-8, 1984.
8.
Kapoor N: Illustrated Tele-Lecture Treatment of ITP in childhood: A case history. Natl. Immunotherapy
Info. Ntwk. 1:6,1985.
9.
Kirkpatrick D, Fitzgerald PA, Kapoor N, Kernan N, Brochstein J, Chaganti R, Siena S, Lopez C: Selective
engraftment of donor-derived hematopoietic cells with minimal evidence of T-cell chimerism in a patient
with juvenile osteopetrosis. Dept. of Health & Human Svcs., Public Health Svc., Ctrs. for Disease Control.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 16 of 29
NON-PEER REVIEW ARTICLES (continued)
10.
Tutschka PJ, Kapoor N: New approaches to bone marrow transplantation. Ohio Medical Education
Network. Vol. 27, October 24-28, 1988.
11.
Kapoor N: High-dose IVIG in the treatment of systemic lupus erythematosus vasculitis. Immunopathology
Immunotherapy Letter 3:2-5, 1988.
12.
Copelan EC, Bechtel T, Featheringham NC, Grose MM, Sedmak DD, Kapoor N, Tutschka PJ: Oral
administration of IgG in marrow transplant recipients. Drug Intelligence and Clinical Pharmacy 22:912,
1988.
13.
Kapoor N, Copelan EA, Tutschka PJ: Infection prophylaxis in bone marrow transplant recipients. IN:
Prospective Indications for Intravenous Immunoglobulins. The MEDICINE Publishing Foundation
Symposium Series 24, pp. 57-61, 1988.
14.
Tutschka PJ, Copelan EA, Kapoor N: Gammaglobulin therapy in bone marrow transplantation. IN:
Intravenous Gammaglobulin Therapy. (Garner, R.J., Sacher, R.A. eds) Arlington, VA: American
Association of Blood Banks, pg. 79-97, 1988.
15.
Graham-Poole J, Gee AP, Casper J, Graham M, Harvey W., Kapoor N, Koch P, Mendenhall N, Norris D,
Prick T, Thomas P: Bone marrow transplantation for advanced neuroblastoma: A multicenter Pog Pilot
Study. In: Advances in Neuroblastoma Research, Alan R. Liss, Inc., 215-223, 1988.
16.
Kapoor N: Graft rejection in bone marrow transplantation. Proceedings of the Global Plenum on Organ
Transplantation, India, 1990.
17.
Kapoor N. Graft-versus-host disease and immunosupperssion. Immunol Res 41/1 (2008), p. 34-44.
18.
Tutschka PJ, Kapoor N: Bone marrow transplantation - Is it the final cure? Ohio Medical Education
Network, Vol. 30, 1991.
19.
Kapoor N, Keever CA, Leong N, Beck EX: Effects of ex-vivo treatment with methylprednisolone and
vincristine on bone marrow lymphohematopoietic cells. Advances in Bone Marrow Purging and
Processing, Vol. 377, 49-56, Wiley-Liss pub.
20.
Hsu S, Isidro G, Kapoor N, Mangan K: Genetic Monitoring of Marrow Engraftment; Using Variable
Number of Tandem Repeats (VNTR) Probes for Recipients of HLA-Identical Sibling Marrow Grafts.
Visuals of the Clinical Histocompatible Work-Shop, 97-98, 1993.
21.
Ezzone S, Jolly D, Replogle K, Kapoor N, Tutschka P: Survey of Oral Hygiene Regimens Among Bone
Marrow Transplant Centers. Oncology Nursing Forum 20(9), 1993.
22.
Kapoor N: Aplastic Anemia: Diagnosis, Prognostic Factors and Treatment. Presentation, Non Neoplastic
Hematopediatrics Symposia, Agrupación Mexicana Para el Estudio de la Hematología AC, April 1999.
ABSTRACTS
1.
Chandler B, Kapoor N, Barker B, Boylis R, Oh W: Nitroblue tetrazolium test in neonates. J. Pediatr.
92:638, 1978.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 17 of 29
ABSTRACTS (Continued)
2.
Gupta S, Kapadia A, Kapoor N, Good RA: Immunoregulatory T-cells in patients with primary
immunodeficiency. Indian J. Med. Res. 69-643, 1979.
3.
Meyers P, Integlia B, Kapoor N, Moore MAS: Activation of fetal hemoglobin synthesis in cultured adult
bone marrow. Blood 54:65a, 1979.
4.
Sorell M, Stevenson R, Kapoor N, Pollack MS, Chaganti Raju SK, Dupont B, Good RA, O'Reilly RJ:
Sustained chimerism without graft-vs.-host-disease (GVHD) in a patient with severe combined
immunodeficiency (SCID) and intrauterine transfusion of maternal T cells. Pediatr. Res. 13:455, 1979.
5.
Pahwa S, Pahwa R, Kapoor N, Good RA: Heterogeneity of B-Lymphocyte differentiation in severe
combined immunodeficiency (SCID). Pediatr. Res. 13:453, 1979.
6.
Sorell M, Rosen JF, Kapoor N, Kirkpatrick D, Chaganti RSK, Pollack MS, Dupont B, Goossen C, Good
RA, O'Reilly RJ: Bone marrow transplant for osteopetrosis in a 10 year old boy. Pediatr. Res. 13:481,
1979.
7.
Sorell M, Kirkpatrick D, Kapoor N, Kapadia A, Pahwa R, Chaganti RSK, Dupont B, Good RA, O'Reilly
RJ: Bone marrow transplant for combined immune deficiency (CID) and agranulocytosis associated with
cartilage-hair hypoplasia (CHH). Pediatr. Res. 13:455, 1979.
8.
Andreeff M, Beck JD, Kapoor N, Steinmetz J, Melamed MR, Gee T, Miller D, Clarkson B: Clonal
evolution in acute leukemia: Analysis of subpopulations by velocity sedimentation and multiple markers.
Proc. of Amer. Assoc. Can. Res. 20:112, 1979.
9.
O'Reilly RJ, Pahwa R, Sorell M, Kapoor N, Kapadia A, Kirkpatrick D, Pollack MS, Dupont B, Incefy G,
Iwata T, Good RA: Transplantation of fetal liver and thymus in patients with severe combined
immunodeficiencies. Proceedings of Serono Symposia: Vol. 27, Stresa, Italy, 1978. The Immune System:
Functions and Therapy of Dysfunction. (Doria, G. and Eschkol, A., eds). Academic Press, NY, pp.
241-253, 1980.
10.
Gupta S, Kapoor N: Lymphocyte subpopulation: Surface intracellular enzymatic markers and functions. In:
Infectious Complicating the Abnormal Host (Grieco, M.H., ed.). Yorke Medical Books, pp. 84-128, 1980.
11.
Kapoor N, Kirkpatrick D, Blaese MR, Oleske J, O'Rielly RJ: Reconstitution of normal
megakaryocytopoiesis and immunologic functions in Wiskott Aldrich Syndrome by marrow transplantation
following myeloablation and immunosuppression with Busulfan and Cyclophoshamide. Pediatr. Res.
14:548, 1980.
12.
Platsoucas CD, Kapoor N, Beck JD, Good RA, Gupta S: T-cell differentiation in human bone marrow. In
vitro induction by thymopoietin pentapeptide and unbiquitin. Clin. Res. 28:358a, 1980.
13.
Kapoor N, Good RA, Gupta S: Histamine-induced T-cell mediated suppression of colony forming units
(CFU-C) in culture. Int. Congress of Immunology, 4th, Paris, 1980. Abstracts (Preud'home and Hawken,
V.A.L., eds.). Paris French Soc. of Immunology, 1980. Abstract 4.7.34.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 18 of 29
ABSTRACTS (continued)
14.
Reisner Y, Kapoor N, O'Reilly RJ, Good RA: Colony forming cells (CFU-c) isolated from monkey and
human bone marrow with soybean agglutinin for immunologic reconstitution. Int. Congress of
Immunology, 4th Paris, 1980. Abstracts (Preud'home, J.L. and Hawken, V.A.L., eds.). Paris French Soc.
of Immunology, 1980. Abstract 14.2.11.
15.
Incefy GS, O'Reilly RJ, Iwata T, Kapoor N, Goldstein G, Dardenne M, Back JF, Good RA: In vitro
differentiation of human T-cell precursors by thymic peptides in health and immunodeficiency. Int.
Congress of Immunology, 4th, Paris, 1980. Abstracts (Preud'home, J.L. and Hawken, V.A.L., eds.), Paris
French Soc. of Immunology, 1980. Abstract 14.2.11.
16.
O'Reilly RJ, Reisner Y, Kapoor N: The use of separated allogeneic hematopoietic precursors to circumvent
graft-vs.-host-disease following marrow transplantation. In: Cancer - Achievements, Challenges, and
Prospects for the 1980's (Burchenal, J.H. and Oettgen, H.F.). Proceedings of the 1980 International
Symposium on Cancer, New York, 1980. Vol. 2, Grune and Stratton, Inc., pp. 649-662, 1981.
17.
Reisner Y, Kapoor N, Shank B, Csurney R, Good RA, O'Reilly RJ: Allogeneic bone marrow
transplantation in monkeys using stem cells fractionated by sheep red blood cells and soybean agglutinin.
FASEB (Atlanta) 40:1166, 1981.
18.
Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Shank B, O'Reilly RJ: Bone marrow transplantation
(BMT) for acute leukemia in remission. Proc. Am. Soc. Clin. Onc. (5/81) 22:491, 1981.
19.
Kirkpatrick D, Lopez C, Kapoor N, O'Reilly RJ, Ching C: Natural killer cell activity in marrow deficiency
states. 10th Cong. Int. Soc. Exp. Hematol. (8/81) 9:1981.
20.
O'Reilly RJ, Kapoor N: Immunologic function in patients transplanted for severe combined
immunodeficiency selectively engrafted with donor T-lymphocyte. Workshop for "The Role of the Thymus
in the Generation of the T-cell Repertoire." Presented in Rudesheim, 1981.
21.
Platsoucas CD, Kapoor N, Beck JD, Gupta S, Good RA: Separation of human bone marrow cells by
density gradient electrophoresis. Electrophoresis '81 International Conference, Charleston, SC, April 1981.
22.
Shank B, Hopfan S, Kim JH, Chu F, Grossbard E, Kapoor N, Kirkpatrick D, Dinsmore R, Simpson L, Reid
A, Chui C, Finegan D, O'Reilly RJ: Hyperfractionated total body irradiation for bone marrow
transplantation. I. Early results in leukemia patients. ASTR 22nd Meeting, Dallas, Texas, 1980. Int. J.
Radiat. Oncol. Biol. Phys. 6(3), 1981.
23.
Simpson L, Reid A, Hopfan S, Shank B, Finegan D, Chui C, O'Reilly RJ, Grossbard E, Kapoor N,
Dinsmore R, Kirkpatrick D, Kim J, Chu F: Hyperfractionated total body irradiation for bone marrow
transplantation. II. Physical aspects of the combined electron-photon treatment plan. ASTR 22nd
Meeting, Dallas, TX, October 1981. In: Int. J. Radiat. Oncol. Biol. Phys. 6(3), 1981.
24.
Dinsmore R, Shank B, Kapoor N, Teitelbaum H, Kirkpatrick D, Clarkson B, Miller DR, O'Reilly RJ: A
randomized trial of marrow transplantation (BMT) vs. chemotherapy (CT) maintenance for acute
myelogenous leukemia in first remission: Preliminary results. 10th Cong. Int. Soc. Exp. Hematology (8/81)
9:125, 1981.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 19 of 29
ABSTRACTS (continued)
25.
Shank B, Chu FCH, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Reid A, Bonfiglio P, Simpson
L, O'Reilly RJ: Hyperfractionated total body irradiation for bone marrow transplantation. III. Results in
seventy leukemia patients with allogeneic transplants. Int. J. Radiat. Oncol. Biol. Phys. 7, 1981.
26.
Castro-Malaspina H, Gay RE, Jhanwar SC, Hamilton J, Kapoor N, Chiarieti D, Meyers P, Gay S, Moore
M: Characteristics of bone marrow fibroblasts from patients with myeloproliferative disorders. Proc. Am.
Assoc. Con. Res. 22:59, 1981.
27.
Nir Y, Tamaroff M, Straker N, O'Reilly RJ, Kapoor N: Psychological development of infants with severe
combined immune deficiency (SCID) in a reverse isolation environment. Proceeding of ASCO 22:398,
1981.
28.
O'Reilly RJ, Pollack MS, Auerbach A, Kapoor N, Kirkpatrick D, Chaganti RSK, Dupont B: HLA
histocompatibility between parent and affected child in Fanconi's anemia. Soc. Pediatr. Res. (5/82)
16:210a, 1981.
29.
Pollack MS, Kirkpatrick D, Kapoor N, Evans R, Dupont B, O'Reilly RJ: The identification of intrauterine
derived maternal T-cells in four severe combined immunodeficiency patients by HLA typing. Soc. Pediatr.
Res. (5/82) 16:230a, 1982.
30.
Kapoor N, O'Reilly RJ, Kirkpatrick D, Pollack MS, Dupont B, Good RA, Reisner Y: Restoration of
immunological function by a histoincompatible, T cell depleted marrow transplant in a child with severe
combined immunodeficiency. Soc. Pediatr. Res. (5/82) 16:224a, 1982.
31.
Kirkpatrick D, Kapoor N, Sorell M, Dinsmore R, O'Reilly RJ, the MSKCC Transplant Service: Improved
prognosis of severe aplastic anemia in black children treated with anti-lymphocyte globulins. Soc. Pediatr.
Res. (5/82) 16(4):207a, 1982.
32.
Kirkpatrick D, Kapoor N, Bernalis R, Pollack MS, Dupont B, O'Reilly RJ: Successful reversal of
materno-fetal graft vs. host disease in a patient with severe combined immunodeficiency by
immunosuppression, and transplantation of HLA-D compatible paternal marrow. Soc. Pediatr. Res. (5/82)
16(4):225a, 1982.
33.
O'Reilly RJ, Riech L, Gold J, Kirkpatrick D, Dinsmore R, Kapoor N, Condie R: A randomized trial of
intravenous hyperimmune globulin for the prevention of cytomegalovirus (CMV) infections following
marrow transplantation: Preliminary results. IXth Int. Cong. Transplant. Soc., Brighton, UK, August 1982.
34.
Dinsmore R, Kapoor N, Kirkpatrick D, Flomenberg N, Gulati S, O'Reilly RJ: Marrow transplantation for
acute lymphoblastic leukemia (ALL) in remission: The importance of early transplantation. I3th Int. Cong.
Transplant. Soc., Brighton, UK, August 1982.
35.
Kirkpatrick D, Jones B, Dinsmore R, Young C, O'Reilly RJ, Kapoor N, Lopez C, Fox J, the Bone Marrow
Transplantation Service: Early trials of FIAC (2'Fluor-5 IODO-ARACYTOSINE) in the treatment of
cytomegalovirus interstitial pneumonia in bone marrow transplant recipients. 13th Int. Cancer Congress,
Seattle, WA, September 1982.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 20 of 29
ABSTRACTS (continued)
36.
Pollack MS, Kapoor N, Kirkpatrick D, Reisner Y, Dupont B, O'Reilly RJ: HLA marker studies in
monitoring engraftment following transplantation of histoincompatible, T-cell depleted marrow in patients
with severe combined immunodeficiency and leukemia. Third Int. Immunological Monitoring Symp., Key
Biscayne, FL, November 21-24, 1982.
37.
O'Reilly RJ, Kapoor N, Kirkpatrick D: Marrow transplantation for congenital diseases. Int. Soc. Exp.
Hematol., Baltimore, MD, August 23-27, 1982.
38.
Kirkpatrick D, Dinsmore R, Kapoor N, Gulati S, Flomenberg N, Condie R, O'Reilly RJ: (Int. L.
Delmonte). Initial trials of Minnesota antithymocyte globulin in the treatment of severe aplastic anemia.
Am. Soc. Hematol., Washington, DC, December 1982.
39.
Ebell WH, Castro-Malaspina H., Kapoor N, et al: Radiation sensitivity of bone marrow fibroblast
colony-forming cells (CFU-F) and granulocyte macrophage colony- forming cells (CFU-GM). Blood
60:167a, 1982.
40.
Ebell WH, O'Reilly RJ, Castro-Malaspina H, Kapoor N, et al: Human bone marrow stromal cells express
receptors for soybean aggluntinin (SBA). Implications for marrow transplantation. Blood 60:167a, 1982.
41.
O'Reilly RJ, Kapoor N, Kirkpatrick D, Hodes MZ, Ebell W, Pollack MS, Dupont D, Good RA, Reisner Y:
Transplantation of histoincompatible, soybean lectin (SBA) separated, E-rosette depleted marrow for severe
combined immunodeficiency (SCIA) and leukemia: Early results in high risk patients. Blood 60:171a, 1982.
42.
Kapoor N, Reisner Y, O'Reilly RJ, Good RA: Histoincompatible Marrow Transplant. Tenth Annual
International Advanced Apheresis Seminar, Braintree, MA, May 16-17, 1983.
43.
Kapoor N, Jung L, Taylor T, DeBault L, Muncer R, Nitschke R, Brubaker D, Good RA: An
immunosuppressive, myeloablative preparative regimen adequate for matched sibling transplant, inadequate
in histoincompatible, T-cell-depleted marrow transplant in leukemia. The Fourth Immune Monitoring
Symposium, University of Texas, Houston, TX, November 2-5, 1983.
44.
Kapoor N, Filler J, Humphrey GB, Good RA: High dose intravenous gamma globulin as an alternate
therapeutic modality in Evan's syndrome. Am. Soc. Hematol., 25th Annual Meeting, San Francisco, CA,
December 1983.
45.
Engelhard D, Landreth KS, Kapoor N, Kincade PW, Good RA: Cycling of Pre-B cells and CFU-C in
cyclic neutropenia. Blood 62:133a, 1983.
46.
O'Reilly RJ, Brochstein J, Kirkpatrick D, Hodes M, Kernan N, Collins N, Siena S, Shank B, Wolf L,
Kapoor N, Pollack MS, Dupont B, Reisner Y: Transplantation of histoincompatible, soybean lectin (SBA)
separated, E-rosette depleted marrow fro severe combined immunodeficiency (SCID) and leukemia:
MHC-related graft resistance in leukemic transplant recipients. Blood 62:227a, 1983.
47.
Cowan M, Ammann A, Wara D, Weintrub P, Pabst H, Martin N, Arias N, Kapoor, N: Mismatched bone
marrow transplantation (BMT) using soybean agglutinin (SBA) negative marrow cells. Pediatr. Res.
18:254a, 1984.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 21 of 29
ABSTRACTS (continued)
48.
Jung LKL, Fu SM, Hara T, Kapoor N, Good RA: Absence of T cell antigen associated with glycoprotein
Tp40 in severe combined immunodeficiency. Clin. Res. 33:557a, 1985.
49.
Tutschka PJ, Copelan EA, Kapoor N: Bone marrow transplantation for leukemia without total body
irradiation. Blood 70(#5, Suppl.1): 300a, 1987.
50.
Kapoor N, Tutschka PJ, Copelan EA: Prevention of fatal CMV infection by administration of intravenous
gammaglobulin. Blood 70(#5, suppl. 1): 308a, 1987.
51.
Kapoor N, Filler J, Jyonouchi H, Gonzalez N, Jung L, Good RA: Correction of Wiskott-Aldrich syndrome
with histoincompatible "E rosette"-depleted marrow transplantation. Bone Marrow Transplant. 2:132,
1987.
52.
Incefy GS, Flomenberg N, Small T, Kernan NA, Brochstein J, Kirkpatrick D, Kapoor N, Groshen S,
O'Reilly RJ: Appearance of thymulin in plasma follows lymphoid chimerism and precedes development of
immunity in patients with SCID transplanted with T cell-depleted haploidentical marrow. Proceedings of
UCLA Symposia on BMT, Tamarron, CO, March 1988.
53.
Tutschka PJ, Copelan EA, Kapoor N: Replacing total body irradiation (TBI) with Busulfan (Bu) as
conditioning of patients with leukemia for allogeneic marrow transplantation. XII International Congress of
the Transplantation Society, Sydney, Australia, 1988.
54.
Kapoor N, Copelan EA, Tutschka PJ: Infections in bone marrow transplantation. Intravenous
Immunoglobulins Prospective Indications, Cardiff, UK, March 1988.
55.
Kapoor N, Tutschka PJ, Copelan EA: Differential lymphohematopoietic effects of glucocorticoid. XXII
Congress of the International Society of Hematology, Milan, Italy, August 1988.
56.
Copelan EA, Tutschka PJ, Kapoor N: Bone marrow transplantation without total body irradiation in
patients 40 and older. XXII Congress of the International Society of Hematology, Milan, Italy, August
1988.
57.
Tutschka PJ, Copelan EA, Kapoor N: Experience with intravenous immunoglobulins (IVIG) in BMT.
XXII Congress of the International Society of Hematology, Milan, Italy, August 1988.
58.
Kapoor N, Copelan EA, Tutschka PJ: Cyclosporine in the treatment of aplastic anemia. Blood 72:44a,
1988.
59.
Copelan EA, Grever M, Kapoor N, Tutschka PJ: Marrow transplantation following busulfan and
cyclophosphamide for chronic myelogenous leukemia in accelerated or blastic phase. Blood 72:383a, 1988.
60.
Tutschka PJ, Copelan EA, Kapoor N: Bone marrow transplantation for advanced acute lymphocytic
leukemia (ALL) after Busulfan (BU) and Cyclophosphamide (CY) conditioning. Blood 72:411a, 1988.
61.
Kapoor N, Copelan EA, Tutschka PJ: Cytomegalovirus (CMV) infection in bone marrow transplant
recipients: Use of intravenous gammaglobulin as prophylactic and therapeutic agents. Transplant. Proc.
21(1):1056a, 1989.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 22 of 29
ABSTRACTS (continued)
62.
Tutschka PJ, Copelan EC, Kapoor N: Bone marrow transplantation for advanced adult ALL - Results after
conditioning with chemotherapy instead of total body irradiation. American Federation for Clinical
Research, April 1989.
63.
Copelan EC, Sheridan JF, Sedmak DD, Kapoor N, Tutschka PJ: IgG subclass deficiency and
pneumococcal infection following allogeneic bone marrow transplantation. American Federation for
Clinical Research, April 1989.
64.
Kapoor N, Copelan EC, Tutschka PJ: Cyclosporine as immunomodulator in the treatment of aplastic
anemia. American Federation for Clinical Research, April 1989.
65.
McNeil DL, Sedmak D, Jordan SC, Kapoor N, Boxer LA: Combined neutropenia and IgG subclass
deficiency. American Academy of Allergy and Immunology.
66.
Tutschka PJ, Copelan EA, Kapoor N: Bone marrow transplantation for adult acute lymphocytic leukemia
after conditioning with 16 mg/kg of busulfan and 120 mg/kg of cyclophosphamide. Exp. Hematol.
17(6):210a, 1989.
67.
Tutschka PJ, Kapoor N, Copelan EA: A non-infectious, steroid responsive febrile syndrome in the very
early post-transplant phase after allogeneic marrow grafting. Exp. Hematol. 17(6):192a, 1989.
68.
Copelan EA, Kapoor N, Tutschka PJ: Busulfan and cyclophosphamide and marrow transplantation in
patients with lymphoma and poor prognostic features. Exp. Hematol. 17(6):164a, 1989.
69.
Copelan EA, Kapoor N, Tutschka PJ: Marrow transplantation in individuals with myelodysplasia or
leukemia following myelodysplasia. Exp. Hematol. 17(6):176a, 1989.
70.
Kapoor N, Copelan EA, Tutschka PJ: Effects of high doses of intravenous gammaglobulin on
cytomegalovirus infection in allogeneic bone marrow transplant recipients. Exp. Hematol. 17(6):190a,
1989.
71.
Kapoor N, Tutschka PJ, Copelan EA: Bone marrow purging with glucocorticoids. Proceedings of Second
International Symposium on Bone Marrow Purging and Processing, Cancun, Mexico, 1989.
72.
Kapoor N, Copelan EA, Klein J, Tutschka PJ: Acute and chronic graft-versus-host disease OSU bone
marrow transplant service experience. Bone Marrow Transplantation in Children and Adults: New Trends
in the Therapy of Leukemia and Lymphoma, No.4:105, September 1989.
73.
Kapoor N, Wolverton S, Copelan EA, Tutschka PJ: Psoralen and ultraviolet A radiation (PUVA) in the
treatment of resistant chronic graft-versus-host disease (GVHD). Blood 74(#7, Suppl. 1):181a, 1989.
74.
Theil KS, Winter JA, Kapoor N, Tutschka PJ, Copelan EA: Cytogenetic studies in chronic myelogenous
leukemia following bone marrow transplantation. Blood 74(#7, Suppl. 1):1624a, 1989.
75.
Theil KS, Winter JA, Kapoor N, Tutschka PJ, Copelan EA: Donor-recipient chimerism and graft vs. host
disease following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Blood
74(#7, Suppl. 1): 1625a, 1989.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 23 of 29
ABSTRACTS (continued)
76.
Kapoor N, Wolverton S, Copelan EA, Tutschka PJ: Psoralen and ultraviolet A radiation (PUVA) in the
treatment of resistant chronic graft-vs-host disease (GVHD). Exp. Hematol. 18(6):47a, 561, 1990.
77.
Copelan EA, Klein J, Bechtel T, Kapoor N, Featheringhan N, Grose M, Tutschka PJ: Molina A, Parker P,
Stein AS, Spielberger R, Nademanee A, Snyder DS, O'Donnell MR, Smith EP, Margolin K, Dagis A,
Planas I, Kashyap A, Somlo G, Kapoor N, Vora N, Niland J, and Forman SJ. Allogeneic Bone Marrow
Transplantation (BMT) in Patients (PTS) With Incurable Low Grade Lympholiferative Disorders (LGLPD).
Blood 88 (10 Suppl 1):2465, 1996.Oral administration of immune serum globulin in marrow transplant
recipients. Exp. Hematol. 18(6):558a, 1990.
78.
Copelan EA, Biggs JC, Thompson JM, Crilley P, Szer J, Kapoor N, Klein JP, Tutschka PJ: A multiinstitutional trial of BUCY2 followed by allogeneic marrow transplantation in AML. Exp. Hematol.
18(6):596a, 1990.
79.
Avalos BA, Tutschka PJ, Kapoor N, Cunningham I, Copelan EA: Busulfan and cyclophosphamide as a
preparative regimen for marrow transplantation for lymphoma. Exp. Hematol. 18(6):421a, 1990.
80.
Copelan EA, Klein J, Bechtel T, Kapoor N, et al: Oral administration of immune serum globulin in marrow
transplant recipients. Exp. Hematol. 18(6), #558, 1990.
81.
Keever CA, Kapoor N, Copelan EA, Avalos BR, Meister R, Leong N, Tutschka PJ: HLA-A locus directed
marrow graft rejection in the absence of additional risk factors. Blood 76(10):547a, 1990.
82.
Tutschka PJ, Copelan EA, Kapoor N, Avalos BR: Bone marrow transplantation for advanced, high risk
leukemia using Bu16-Cy120. Blood 76(10):569a, 1990.
83.
Replogle K, Jolly D, Ezzone S, Burke E, Tutschka PJ, Kapoor N: Survey of oral hygiene regimens among
bone marrow transplant centers. J. Dental Res. 70:581a, 1991.
84.
Kapoor N, Avalos BR, Copelan EA, Cunningham I, Klein J, Keever CA, Tutschka PJ: Bone marrow
transplantation for multiple myeloma with busulfan and cyclophosphamide conditioning regimen: Slow
disappearance of plasma cells from bone marrow following transplantation. Exp. Hematol. 19:574, 1991.
85.
Kapoor N, Keever CA, Beck EX, Leong N: Effect of ex-vivo treatment with methylprednisolone and
vincristine on bone marrow lymphohematopoietic cells. Exp. Hematol. 19:567, 1991.
86.
Tutschka PJ, Kapoor N, Copelan EA, Avalos BR, Klein J, Cunningham I: Early experience with 16mg/kg
of busulfan and low dose cyclophosphamide of 90 mg/kg as conditioning for allogeneic marrow grafting in
leukemia. Exp. Hematol. 19:570, 1991.
87.
Avalos BR, Cunningham I, Tutschka PJ, Kapoor N, Klein J, Keever CA, Copelan EA: Allogeneic marrow
transplantation with busulfan and cyclophosphamide for chronic myelogenous leukemia in chronic or
accelerated phase. Exp. Hematol. 19:573, 1991.
88.
Copelan EA, Biggs JC, Szer J, Kapoor N, Cunningham I, Avalos BR, Atkinson K, Klein J, Keever CA,
Tutschka PJ: Preparation for marrow transplantation in adults with acute lymphobalstic leukemia using
busulfan and cyclophosphamide. Exp. Hematol. 19:575, 1991.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 24 of 29
ABSTRACTS (continued)
89.
Keever CA, Klein J, Kapoor N, Copelan EA, Avalos BR, Cunningham I, Leong N, Tutschka PJ:
Characterization of effector cells mediating graft rejection following transplantation of MHC identical
unrelated marrow. Exp. Hematol. 19:381, 1991.
90.
Keever CA, Leong N, Cunningham I, Copelan EA, Avalos BR, Klein JL, Kapoor N, Tutschka PJ: HLAB44.2 directed cytotoxic T cells associated with acute graft-vs-host disease following unrelated marrow
transplantation. Proceedings of The American Society for Histocompatibility and Immunogenetics,
October 1991.
91.
Keever CA, Leong N, Kapoor N, Avalos BR, Copelan EA, Cunningham I, Klein JL, Tutschka PJ: The
effect of graft versus host disease on the recovery of NK activity and LAK precursors following bone
marrow transplantation. Blood, 78(10, Suppl. 1), #1136, 1991.
92.
Tuschka PJ, Kapoor N, Copelan EA, Avalos BR, Klein J, Cunningham I: Early experience with 16 mg/kg
of busulfan and low dose cyclophosphamide of 90 mg/kg as conditioning for allogeneic marrow grafting in
leukemia. Exp. Hematol. 19:570, #427a, 1991.
93.
Biggs JC, Atkinson K, Avalos BR, Copelan EA, Crilley P, Downs K, Kapoor N, Szer J, Tuschka PJ: A
multinstitutional study of BuCy2 followed by allogeneic marrow transplantation in CML. Exp. Hematol.
19:572 #436a, 1991.
94.
Avalos B, Cunningham I, Tutschka PJ, Kapoor N, Klein J, Keever CA, Copelan EA: Allogeneic marrow
transplantation with busulfan and cyclophosphamide for chronic myelogenous leukemia in chronic or
accelerated phase. Exp. Hematol. 19:573, #440a, 1991.
95.
Kapoor N, Avalos BR, Copelan EA, Cunningham I, Klein J, Keever C, Tutschka PJ: Bone marrow
transplantation for multiple myeloma with busulfan and cyclophosphamide conditioning regimen: Slow
disappearance of plasma cells from bone marrow following transplantation. Exp. Hematol. 19:574, #443a,
1991.
96.
Copelan EA, Biggs JC, Szer J, Kapoor N, Cunningham I, Avalos BR, Atkinson K, Klein J, Keever C,
Tutschka PJ: Preparation for marrow transplantation in adults with acute lymphoblastic leukemia using
busulfan and cyclophosphamide. Exp. Hematol. 19:575, #4501, 1991.
97.
Keever CA, Klein J, Kapoor N, Copelan EA, Avalos BR, Cunningham I, Leong N, Tutschka PJ:
Characterization of effector cells mediating graft rejection of a major histocompatibility complex (MHC)
identical unrelated marrow. Exp. Hematol. 19:581, #471a, 1991.
98.
Keever CA Baxter-Lowe LA Leong N, Cunningham I, Copelan EA, Avalos BR, Klein J, Kapoor N, Adams
P, Tutschka PJ: Cytolytic T-cells recognizing a new HLA-B44 antigen following unrelated marrow
transplant. AAI/CIS Meeting, 1991.
99.
Olson T, Kapoor N, Wing C, Tutschka PJ: Megakaryocyte colony stimulating activity in bone marrow
transplant recipients prepared with busulfan and cyclophosphamide: Blood, 78(10, Suppl. 1), #947, 1991.
100.
Copelan EA, Avalos BR, Klein JL, Kapoor N, Klein J: Reduction in the incidence of transplant-related
death using methotrexate, cyclosporine and pentoxifylline compared to cyclosporine and
methylprednisolone for prevention of graft-versus-host disease following conditioning with BuCy. Blood
80 (10, Suppl.1):236a, 1992.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 25 of 29
ABSTRACTS (continued)
101.
Kapoor N, Beck E, Ezzone S, Klein JL, Avelos BR, Khandelwal K, Blazina J, Copelan E: Use of high dose
VP-16 to Mobilize PBSC/PC. Blood 82 (10, Suppl.1):633a, 1993.
102.
Molina A, Nademanee A, O'Donnell MR, Snyder DS, Stein AS, Parker PM, Smith EP, Lee J, Planas I,
Kashyap A, Spielberger RT, Margolin K, Somlo G, Kapoor N, Chow W., Vora N., Sniecinski I, Niland J,
and Forman SJ. High Dose Chemo/radiotherapy (HDT) and G-CSF Primed Peripheral Blood Stem Cell
Transplantation (PBSCT) In Folicular Low Grade (FLGL) and Transformed (TL) Lymphoma. Blood 88 (10
Suppl 1):472, 1996.
103.
Molina A, Parker P, Stein AS, Spielberger R, Nademanee A, Snyder DS, O'Donnell MR, Smith EP,
Margolin K, Dagis A, Planas I, Kashyap A, Somlo G, Kapoor N, Vora N, Niland J, Forman SJ: Allogeneic
Bone Marrow Transplantation (BMT) in Patients (PTS) With Incurable Low Grade Lymphoproliferative
Disorders (LGLPD). Blood 88 (10 Suppl 1):2465, 1996.
104.
Kapoor N, Kohn D, Crooks G, Weinberg K, Epport K, Kaufman F, Parkman R: Second Hematopoietic
Stem Cell Transplantation (HSCT) In Children: Feasibility and Outcome. Blood 92 (10 Suppl 1):542,
1998.
105.
Parkman R, Kapoor N, Chan R, Burrotto F, and Weinberg K: Defective Antibody Responses To Naturally
Occurring Bacterial Carbohydrate Antigens Following Bone Marrow Transplantation (BMT): Blood 92 (10
Suppl 1):1314, 1998.
106.
Kapoor N, Crooks GM, Kohn DB, Parkman R and Weinberg KI: Treatment of Refractory Acute and
Chronic Graft Versus Host Disease with Daclizumab (Zenapax®). Int. J. Mol. Med. 4(Suppl):288, 1999.
107.
Franklin J, Ortega J, Kapoor N, Rios P, Mascarenhas L, Hofstra T, Weinberg K, Chu J, Anderson C,
Rowland J: Childhood Non-Hodgkin’s Lymphomas (NHL) in Acquired and Congenital Immunodeficiency
Patients. Blood 94(10, Suppl 1):435a, abstract #1933, 1999.
108.
Kapoor N, Crooks GM, Kohn DB, Shah AJ, Monforte H, Rubenstein, P, Parkman R, Weinberg KI:
Inadvertent Transplantation of Placental Cord Blood from an Infant with Klinefelter Syndrome: Blood
94(10, Suppl 1):392b, abstract #4980, 1999.
109.
Shah A, Kapoor N, Weinberg K, Chan R, Brakensiek C, Parkman R: Blastogenic Responses of Normal
Umbilical Cord Blood T Lymphocytes: Blood 94(10, Suppl 1):58b, abstract #3415, 1999.
110.
Kapoor N, Ross L, Weinberg KI, Shah AJ, Crooks GM, Kohn DB, Inderlied C, Parkman R: Adenovirus
Infection: A Major Infectious Cause of Morbidity and Mortality in Children Undergoing Hematopoietic
Stem Cell (HSC) Transplantation. Blood 94(10, Suppl 1):332a, abstract #1482, 1999.
111.
Ross LA, Kapoor N, Weinberg K, Inderlied C, Parkman R: Adenovirus (Adv) Infections as an Important
Cause of Mortality and Tissue Injury in Children undergoing Hematopoietic Stem Cell Transplantation
(HSC). Presented at a Poster Session at 37th Annual Infectious Disease Society of America, Philadelphia,
PA, November 19, 1999.
112.
Kapoor N, Shah AJ, Hoffman J, Crooks GM, Kohn DB, Weinberg KI, Killen R, Wilson K, Inderlied CB,
Ross LA, Parkman R: Cidofovir for Treatment of Adenoviral Infections in Pediatric Hematopoietic Stem
Cell Transplant Recipients. Blood, 96(11):189, abstract #812, 2000.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 26 of 29
ABSTRACTS (continued)
113.
Kapoor N, Shah AJ, Hoffman J, Crooks GM, Kohn DB, Weinberg KI, Killen R, Wilson K, Inderlied CB,
oss LA and Parkman R. Cidofovir for Treatment of Adenoviral Infections in Pediatric Hematopoietic Stem
Cell Transplant Recipients. American Society of Hematology, Blood, 96, (11)812, pg. 189, 2000.
114.
Kapoor N. Current Status of Allogeneic Hematopoietic Stem Cell Transplant for Leukemia. 5 th Sass
International Conference on Emerging Concepts in Leukemia and Lymphoma. Indian Journal of Medical &
Paediatric Oncology, Vol. 24, No. 3 (Suppl), pg. 37, 2003.
115.
Kapoor N. Immunological Recovery Following Hematopoietic Stem Cells Transplant for Leukemia and
Lymphoma. Cancer Detection and Prevention 2004 Symposium Volume, pg. S-154, February 7-10, 2004.
116.
Jeff Davies, Marcos De Lima, Laurence Cooper, Thomas Spitzer, Neena Kapoor, Lisa Brennan, Peter
Thall, John McMannis, Richard Champlin, Lee Nadler and Eva Guinan. Phase I Clinical Study of Adoptive
Immunotherapy with Delayed Infusion of Alloanergized Donor T Cells to Improve Immune Reconstitution
After Haploidential Stem Cell Transplantation. American Society of Hematology, Blood, 112 (11) 1156,
pg. 422, 2008.
REVIEW ARTICLES
1.
O'Reilly RJ, Pahwa R, Sorell M, Kapoor N, Kapadia A, Kirkpatrick D, Pollack MS, Dupont B, Incefy G,
Iwata T, Good RA: Transplantation of fetal liver and thymus in patients with severe combined
immunodeficiencies. In: Proceeding Serono Symposia. Vol. 27, Stresa, Italy, 1978. The Immune System
Functions and Therapy. Dysfunction Doria, G. and Eshkol, A., (eds.) Academic Press, pp. 241-253, 1980.
2.
O'Reilly RJ, Kapoor N, Kirkpatrick D: Fetal tissue transplants for severe combined immunodeficiency:
Their limitations and function potential. Proceedings of the Symposium of Primary Immunodeficiencies,
Royaymont, France, Seligman, M. and Hitzig, W.H., (eds.) Elsevier/North Holland Biomedical Press, p.
419, 1980.
3.
Good RA, Kapoor N, Pahwa R, West A, O'Reilly RJ: Current approaches to the primary
immunodeficiencies. In: International Congress of Immunology 4th, Paris, 1980. Immunology 1980;
Proceedings, Fougereau, M. and Dausset, J (eds.) Academic Press, New York, pp. 907-929, (Progress in
Immunology, IV), 1980.
4.
Kapoor N: Review: Ongoing Progress in the Treatment of Childhood Rhabdomyosarcoma. Oncology
7(1):71-90, 1993.
LETTERS TO THE EDITOR
1.
Perry R, Penk J, Kapoor N, Shah AJ. Gemtuzumab Ozogamicin Exposure and Portal Fibrosis. Pediatr
Blood Cancer 2005; 45:82-83.
BOOK CHAPTERS
1.
O'Reilly RJ, Reisner Y, Kapoor N: The use of separated allogeneic hematopoietic precursors to circumvent
graft-versus-host disease following marrow transplantation. In: Cancer: Achievements, challenges and
prospects for the 1980's. Burchenal, J.H. and Oettgen, H.F. (eds.) Vol. 2: 649-662, 1980.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 27 of 29
BOOK CHAPTERS (Continued)
2.
Gupta S, Kapoor N: Human lymphocyte subpopulations: Surface, intracellular, enzymatic markers and
functions. In: Infections in the Abnormal Host. Grieco, M.H. (eds.), pp. 84-128, 1980.
3.
O'Reilly RJ, Kapoor N, Kirkpatrick D, Flomenberg N, Pollack M, Dupont B, Good RA, Reisner Y:
Transplantation of hematopoietic cells for lethal congenital immunodeficiencies. Primary
Immunodeficiency Diseases: Birth Defects Series. Wedgewood, R.J., Rosen, F.S. and Paul, N.W. (eds.),
Vol 19 pp. 129-137, 1983.
4.
Gupta S, Kapoor N: Properties of T-cell subpopulation and identification of IgG and IgM bearing receptor
cells. In: A Handbook of Practical Immunology. Talover, G.P. (ed.) pp. 282-287, 1983.
5.
Reisner Y, Kapoor N, Good RA, O'Reilly RJ: Allogeneic bone marrow transplantation in mouse, monkey
and man using lectin-separated graft. Tolerance in Bone Marrow and Organ Transplantation. Slavin, S.
(ed.), pp. 293-308, 1984.
6.
Kapoor N, Good RA: Bone marrow transplantation in 1984. In: Immune Disorders in Humans. Vol. 9.
Iwanami Immunology Shoten Publishing Co., Inc. Kyoto, Japan, pp. 201-269, in Japanese, 1984.
7.
Kapoor N, Tutschka PJ, Copelan EA: Bone Marrow Purging with Glucocorticoids. Bone Marrow Purging
and Processing, Alan R. Liss, Inc., New York, pp. 39-46, 1989.
8.
Kapoor N: Intravenous immunoglobulin in marrow transplantation. Immunotherapy with Intravenous
Immunoglobulins. Imbach, P. (ed.), pp. 211-217, 1991.
9.
Kapoor N: Graft rejection in bone marrow transplantation. In: Perspectives on Organ Transplant. Kapoor,
V.K., Ghosh, P.K., Mahendra, B., Agarwal, S.S. (ed.), pp. 65-69, 1993.
10.
Kapoor N: Problems and management of graft-vs-host disease (GVHD) in bone marrow transplantation.
In: Perspectives on Organ Transplant. Kapoor, V.K., Ghosh, P.K., Mahendra, B., Agarwal, S.S. (ed.), pp.
70-73, 1993.
11.
Good RA, Kapoor N, Sorell M, Morishima Y, Dupont B, O'Reilly RJ: Current approaches to the primary
immunodeficiencies. Immunology 80, Academic Press, (Fougereau, M. and Dausset, J., eds), pp. 905-929,
1980.
12.
O'Reilly RJ, Reisner Y, Kapoor N: The use of separated allogeneic hematopoietic prescursosrs to circumvent
graft vs. host disease following marrow transplantation. In Cancer. Achievements, Challenges and Prospects
for the 1980's. Burchenal, J.H. and Oettgen, H.F., (eds). Proceedings of the 1980 International Symposium on
Cancer, New York, 1980. Grune and Stratton, Inc. New York, pp. 389-395, 1981.
13.
Meyers PA, Integlia B, Kapoor N, Moore MAS: Activation of fetal hemoglobin synthesis in cultured adult
bone marrow. In: Hemoglobins in Development and Differentiation. (Stamatoyannopoulas, G., and
Neihuis, A.W., eds). Alan R. Liss, Inc., New York, pp. 389-395, 1981.
14.
O'Reilly RJ, Kapoor N, Kirkpatrick D, Flomenberg N, Pollack MS, Dupont B, Good RA, Reisner Y:
Transplantation of hematopoietic cells for lethal congenital immunodeficiencies. March of Dimes Birth
Defects Foundation Workshop on Primary Immunodeficiency Diseases. Alan R. Liss, Inc., New York, pp.
129-137, 1983.
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 28 of 29
BOOK CHAPTERS (Continued)
15.
Reisner Y, Kapoor N, Pollack S, Friedrich W, Kirkpatrick D, Shank B, Csurny R, Pollack MS, Dupont B,
Good RA, O'Reilly RJ: Use of lectins in bone marrow transplantation. In: Advances in Bone Marrow
Transplantation, UCLA Symposia, Alan R. Liss, Inc., New York. 7:355-398, 1983.
16.
Good RA, Kapoor N, Day NK, Reisner Y: Cellular engineering through marrow transplantation. In:
Advances in Immunobiology: Blood Cell Antigens and Bone Marrow Transplantation. Alan R. Liss, Inc.,
New York, NY, pp. 271-298, 1984.
17.
O'Reilly RJ, Keever C, Kernan N, Flomenberg N, Dupont B, Collins N, Brochstein J, Kirkpatrick D,
Kapoor N, Burns J, Reisner Y: Investigation of humoral immune deficiencies following T cell- depleted,
HLA-haplotype mismatched parental marrow transplants for the treatment of severe combined
immunodeficiency. In: Primary Immunodeficiency Diseases. Eibl, M.M., Rosen, F.S. (eds). Elsevier
Science, pp. 301-306, 1986.
18.
Good RA, Kapoor N: Immunorestoration. In: Immunology and Cancer. Symposium on Fundamental
Cancer Research. Margaret Kripke and Philip Frost (eds). University of Texas Press. 38: 1986.
19.
Kapoor N: Current Status of Bone Marrow Transplantation. Advances in Allergy and Immunology.
(Kumar, L. ed) 65-75, 1988.
20.
Kapoor N, Crooks G, Kohn D, Weinberg KI and Parkman R. Allogeneic hematopoietic stem cell
transplantation for metabolic diseases. Clinical Bone Marrow and Stem Cell Transplantation, Second
Edition. Kerry Anderson (Ed), Cambridge University Press, 560-567, 2000.
21.
Shah, AJ, Kapoor N, Crooks G, Kohn DB, Weinberg KI, Parkman RP. Allogeneic hematopoietic stem cell
transplantation for metabolic diseases. In: Clinical Bone Marrow and Stem Cell Transplantation (K
Atkinson, R Champlin, J Ritz, WE Fibbe, P Ljungman, MK Brenner, Eds.). Cambridge University Press,
Cambridge, UK, 2004.
22.
Rappeport, JM, O’Reilly, RJ, Kapoor, N, Parkman, R. Hematopoietic Stem Cell Transplantation for
Severe Combined Immune Deficiency or What the Children have Taught Us. In: Hematopoietic Stem Cell
Transplantation for Immunodeficiency, Part I (Roifman, CM, Guest Editor), Immunology and Allergy
Clinics of North America (Alam, R, consulting Editor), Feb 2010, Volume 30, Number 1.
INVITED PRESENTATIONS
1.
“Stem Cell/Bone Marrow Transplantation – 2007”
Asians for Miracle Marrow Matches
Irvine, CA, July 7, 2007
2.
“Hematopoietic Stem Cell Transplant for Primary Immune Deficiency Diseases: CHLA Experience”
Pediatric Grand Rounds, City of Hope
Duarte, CA, May 15, 2009
3.
“Improving Cellular Therapy for PID Diseases—Recognition, Diagnosis and Management”
NIAID/NIH Workshop
Bethesda, MD, May 22, 2009
CURRICULUM VITAE—Neena Kapoor, MD—2010
Page 29 of 29
4.
“HSCT-Challenges and Prospects: Primary Immune Deficiency Disease and Hematopoietic Stem Cell
Transplantation”
33rd Annual Conference of the Australian and South East Asian Tissue Typing Association (ASEATTA2009)
New Delhi, INDIA, November 12-15, 2009
5.
“Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency”
5th Annual Sudhir Gupta Endowed Chair in Molecular Immunology Symposium
Primary Immunodeficiency Diseases: Bench to Bedside
Newport Beach, CA, October 3, 2009
Updated: February 16, 2016